Stocks and Investing
Stocks and Investing
Wed, October 31, 2018
[ Wed, Oct 31st 2018
] - WOPRAI
[ Wed, Oct 31st 2018
] - WOPRAI
[ Wed, Oct 31st 2018
] - WOPRAI
[ Wed, Oct 31st 2018
] - WOPRAI
[ Wed, Oct 31st 2018
] - WOPRAI
Tue, October 30, 2018
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
[ Tue, Oct 30th 2018
] - WOPRAI
Travis Steed Maintained (AXGN) at Buy with Decreased Target to $43 on, Oct 30th, 2018
Travis Steed of Cantor Fitzgerald, Maintained "AxoGen, Inc." (AXGN) at Buy with Decreased Target from $45 to $43 on, Oct 30th, 2018.
Travis, nor any peers, have made any analyst calls on AXGN in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources